Skip to main content

Prognosis of Prostatic Carcinoma

  • Chapter
Tumors of the Male Genital System

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 60))

Abstract

Approximately 15 years ago the Veterans Administration Cooperative Urological Research Group began a controlled, randomized, prospective study and comparison of various treatments for prostatic carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bailar, J.C., Mellinger, G.T., Gleason, D.F.: Survival rates of patients with prostatic cancer, tumor stage and differentiation–preliminary report. Cancer Chemother. Rep. 50, 129–136 (1966)

    PubMed  Google Scholar 

  2. Blackard, C.E., Byar, D.P., Seal, U.S., Doe, R.P., Veterans Administration Cooperative Urological Research Group: Correlation of pretreatment serum non-protein bound cortisol and total 17-hydroxycorticosteroid values with survival in patients with prostatic cancer. New Engl. J. Med. 291, 751–755 (Oct., 1974 )

    Article  PubMed  CAS  Google Scholar 

  3. Blackard, J.C., Doe, R.P., Mellinger, G.T., Byar, D.P.: Incidence of cardiovascular disease in patients receiving diethylstilbestrol for carcinoma of the prostate. Cancer (Philad.) 26, 249–256 (1970)

    Article  CAS  Google Scholar 

  4. Blackard, J.C., Byar, D.P., Seal, U.S., Doe, R.P., Veterans Administration Cooperative Urological Research Group: Correlation of pre-treatment serum 17-hydroxycorticosteroid values with survival in patients with prostatic cancer. J. Urol. (Baltimore) 113, 517–520 (April, 1975 )

    CAS  Google Scholar 

  5. Byar, D.P.: The Veterans Administration Cooperative Urological Research Group’s studies of cancer of the prostate. Cancer (Philad.) 32, 1126–1130 (1973)

    Article  CAS  Google Scholar 

  6. Gleason, D.F.: Classification of prostatic carcinomas. Cancer Chemother. Rep. 50, 125–128 (1966)

    PubMed  CAS  Google Scholar 

  7. Hovsepian, J.A., Byar, D.P., Veterans Administration Cooperative Urological Research Group: Carcinoma of the prostate: Correlation between radiologic quantitation of metastases and patient survival. Urology 6, 11–16 (1975)

    Article  PubMed  CAS  Google Scholar 

  8. Veterans Administration Cooperative Urological Research Group: Carcinoma of the prostate: Treatment comparisons. J. Urol. (Baltimore) 98, 590–594 (1964)

    Google Scholar 

  9. Veterans Administration Cooperative Urological Research Group: Treatment and survival of patients with cancer of the prostate. Surg. Gynec. Obstet. 124, 1011–1017 (1967)

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1977 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mellinger, G.T. (1977). Prognosis of Prostatic Carcinoma. In: Grundmann, E., Vahlensieck, W. (eds) Tumors of the Male Genital System. Recent Results in Cancer Research, vol 60. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81095-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81095-4_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81097-8

  • Online ISBN: 978-3-642-81095-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics